The Role of Self-efficacy Program for Self-management of People With Type Diabetes Mellitus
23 mei 2026 bijgewerkt door: Nida Ul Hasanat, Gadjah Mada University
The Role of Self-Efficacy Program for Self-Management of People With Type 2 Diabetes Mellitus: A Mixed Methods Exploratory Study
The goal of this clinical trial is to learn if a self-efficacy program can improve diabetes self-management behaviors in adults with Type 2 Diabetes Mellitus attending primary health centers (Puskesmas) in Yogyakarta, Indonesia. The main questions it aims to answer are:
- Does a self-efficacy program improve diabetes self-management behaviors (measured by the Summary of Diabetes Self-Care Activities/SDSCA)?
- Does a self-efficacy program enhance diabetes self-efficacy (measured by the Diabetes Self-Efficacy Scale)? Researchers will compare participants receiving the self-efficacy program (intervention group) to a waiting-list control group to see if the program leads to greater improvements in self-management and self-efficacy.
Participants will:
- Attend four weekly group sessions (60-90 minutes each) covering diabetes knowledge, goal setting, self-monitoring, and peer support
- Complete questionnaires on diabetes self-management and self-efficacy at baseline and after the intervention period
- Selected participants in the intervention group will take part in semi-structured interviews about their experience with the program
Studie Overzicht
Toestand
Voltooid
Conditie
Interventie / Behandeling
Studietype
Ingrijpend
Inschrijving (Werkelijk)
16
Fase
- Niet toepasbaar
Contacten en locaties
In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.
Studie Locaties
-
-
DI Yogyakarta
-
Yogyakarta, DI Yogyakarta, Indonesië, 55272
- Puskesmas (Primary Health Care) Gedongtengen
-
-
Deelname Criteria
Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Volwassen
Accepteert gezonde vrijwilligers
Nee
Beschrijving
Inclusion Criteria:
- individuals diagnosed with Type 2 Diabetes Mellitus for a minimum of one year;
- exhibiting low or moderate scores on the Diabetes Self-management Scale;
- no prior experience with similar programs or concurrent participation in other related activities
Studie plan
Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Ondersteunende zorg
- Toewijzing: Niet-gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Self-Efficacy Program Group
Participants at the intervention Puskesmas received a structured self-efficacy program consisting of four weekly group sessions (60-90 minutes each) delivered by a trained nurse researcher.
Sessions covered diabetes knowledge enhancement, personal goal setting, self-monitoring techniques, peer experience sharing, problem-solving strategies, progress review, and relapse prevention planning.
The program was grounded in Bandura's Self-Efficacy Theory, targeting mastery experience, vicarious experience, verbal persuasion, and physiological/emotional states.
|
A structured group-based behavioral intervention grounded in Bandura's Self-Efficacy Theory.
The program consisted of four weekly sessions (60-90 minutes each) facilitated by a trained nurse researcher.
Session 1 focused on diabetes knowledge enhancement and personal goal setting.
Session 2 covered self-monitoring techniques and identifying barriers to self-care.
Session 3 involved peer experience sharing and problem-solving strategies.
Session 4 included review of progress, reinforcement of skills, and relapse prevention planning.
The intervention targeted four sources of self-efficacy: mastery experience, vicarious experience, verbal persuasion, and physiological/emotional states.
|
|
Geen tussenkomst: Waiting-List Control Group
Participants at the control Puskesmas received usual care as routinely provided by the primary health center (Puskesmas).
No additional intervention was given during the study period.
Participants in this group were offered the self-efficacy program after data collection was completed.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Diabetes Self-Management
Tijdsspanne: Baseline (pre-intervention) and immediately post-intervention (after 4 weeks)
|
Measured using the Summary of Diabetes Self-Care Activities (SDSCA) questionnaire, which assesses self-care behaviors across five domains: general diet, specific diet, exercise, blood glucose testing, and foot care.
Scores represent the number of days per week (0-7) participants performed each self-care activity.
|
Baseline (pre-intervention) and immediately post-intervention (after 4 weeks)
|
|
Diabetes Self-Efficacy
Tijdsspanne: Baseline (pre-intervention) and immediately post-intervention (after 4 weeks)
|
Measured using the Diabetes Self-Efficacy Scale (DSES), which assesses participants' confidence in performing diabetes self-management tasks.
The scale uses a Likert-type response format with higher scores indicating greater self-efficacy.
|
Baseline (pre-intervention) and immediately post-intervention (after 4 weeks)
|
|
Participants' Experiences with the Self-Efficacy Program
Tijdsspanne: Post-intervention (after completion of the 4-week program)
|
Qualitative data collected through semi-structured interviews with a purposive subsample of intervention group participants.
Interviews explored participants' perceptions, experiences, and perceived impact of the self-efficacy program on their diabetes self-management.
Data were analyzed using thematic analysis.
|
Post-intervention (after completion of the 4-week program)
|
Medewerkers en onderzoekers
Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.
Sponsor
Studie record data
Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.
Bestudeer belangrijke data
Studie start (Werkelijk)
14 september 2019
Primaire voltooiing (Werkelijk)
22 oktober 2019
Studie voltooiing (Werkelijk)
15 december 2019
Studieregistratiedata
Eerst ingediend
18 mei 2026
Eerst ingediend dat voldeed aan de QC-criteria
23 mei 2026
Eerst geplaatst (Werkelijk)
29 mei 2026
Updates van studierecords
Laatste update geplaatst (Werkelijk)
29 mei 2026
Laatste update ingediend die voldeed aan QC-criteria
23 mei 2026
Laatst geverifieerd
1 mei 2026
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- 6536/UN1/FPSi.1.3/SD/PT/2019
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Nee
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Nee
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .